China Resources Jiangzhong Pharmaceutical Co.,Ltd (SHA:600750)
26.35
+0.30 (1.15%)
Apr 8, 2026, 3:00 PM CST
SHA:600750 Market Cap
SHA:600750 has a market cap or net worth of 16.4 billion as of April 8, 2026. Its market cap has increased by 17.82% in one year.
Market Cap
16.40B
Enterprise Value
15.04B
Revenue
4.22B
Ranking
n/a
PE Ratio
18.22
Stock Price
26.35
Market Cap Chart
Since January 2, 2001, SHA:600750's market cap has increased from 2.58B to 16.40B, an increase of 536.56%. That is a compound annual growth rate of 7.60%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 7, 2026 | 16.40B | 12.55% |
| Dec 31, 2025 | 14.57B | 3.07% |
| Dec 31, 2024 | 14.14B | 8.64% |
| Dec 29, 2023 | 13.01B | 44.47% |
| Dec 30, 2022 | 9.01B | -0.07% |
| Dec 31, 2021 | 9.01B | 34.83% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Betta Pharmaceuticals | 18.59B |
| Tonghua Golden-Horse Pharmaceutical Industry Co,Ltd | 18.47B |
| Wedge Industrial | 17.90B |
| Shandong Buchang Pharmaceuticals | 17.33B |
| Hybio Pharmaceutical | 17.15B |
| ApicHope Pharmaceutical Group | 16.41B |
| Guangdong Zhongsheng Pharmaceutical | 15.70B |
| Nanjing King-Friend Biochemical Pharmaceutical | 15.62B |